Carbimazole 5mg tablets

国: イギリス

言語: 英語

ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)

有効成分:

Carbimazole

から入手可能:

Advanz Pharma

ATCコード:

H03BB01

INN（国際名）:

Carbimazole

投薬量:

5mg

医薬品形態:

Oral tablet

投与経路:

Oral

クラス:

No Controlled Drug Status

処方タイプ:

Valid as a prescribable product

製品概要:

BNF: 06020200; GTIN: 5060064172025

製品の特徴

OBJECT 1
CARBIMAZOLE 5 MG TABLETS
Summary of Product Characteristics Updated 20-Apr-2021 | ADVANZ Pharma
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Carbimazole 5 mg Tablets
2. Qualitative and quantitative composition
Each tablet contains 5 mg of carbimazole.
Excipients with known effect:
Lactose Anhydrous (140.485 mg per tablet)
For a full list of excipients see section 6.1.
3. Pharmaceutical form
Pale pink, uncoated, round, biconvex tablets marked with LINK C5 on
one side and a scoreline on the
reverse.
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Carbimazole is an anti-thyroid agent. It is indicated in adults and
children in all conditions where reduction
of thyroid function is required.
Such conditions are:
1. Hyperthyroidism.
2. Preparation for thyroidectomy in hyperthyroidism.
3. Therapy prior to and post radio-iodine treatment.
4.2 Posology and metho